Infiltration rate of Deflazacort in therapeutic market (Q3, 2019)
MedAnalytics measures Deflazacort market penetration in different clinical practices. The report is often a source of untapped market potential that might exist in own brand marketing.The market penetration of Deflazacort varied in different clinical practices. last one year period, market penetrations was observed 9% in orthopaedic surgeons, 8% in diabetologists, 8% in ent specialists, 8% in internal medicine specialists, 8% in general physicians, 7% in infertility specialists, 7% in nephrologists, 7% in endocrinologists, 7% in gastroenterologists, 7% in dermatologists, 7% in pediatricians, 6% in hepatologists, 6% in plastic surgeons, 6% in urologists, 6% in ophthalmologists, 6% in respiratory medicine specialists, 6% in physical medicine specialists, 6% in cardiologists, 5% in hepatobiliary surgeons, 5% in orofacial & maxillary surgeons, 5% in pediatric surgeons, 5% in neurosurgeons, 5% in psychiatrists, 5% in neurologists, 5% in cardio-vascular surgeons, 5% in critical care medicine specialists, 5% in rheumatology specialists, 5% in general & laparoscopic surgeons, 5% in gynecologists & obstetricians, 4% in oncologists, 4% in colorectal surgeons, 4% in hematologists, 4% in anesthesia & icu specialists, 3% in cancer surgeons and 3% in dentists.For example, market penetration rate of a generic found 10% in dermatology practice. It means, 10% dermatology practitioners are potential to prescribe this generic. This kind of report is often a source for discovering an untapped market potential that may exist around in marketing own brand.
You might be interested to